Does BREXPIPRAZOLE Cause Disease recurrence? 78 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Disease recurrence have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.6% of all adverse event reports for BREXPIPRAZOLE.
78
Reports of Disease recurrence with BREXPIPRAZOLE
0.6%
of all BREXPIPRAZOLE reports
1
Deaths
13
Hospitalizations
How Dangerous Is Disease recurrence From BREXPIPRAZOLE?
Of the 78 reports, 1 (1.3%) resulted in death, 13 (16.7%) required hospitalization, and 1 (1.3%) were considered life-threatening.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which BREXPIPRAZOLE Alternatives Have Lower Disease recurrence Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE